These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 24121189)
1. Surveillance for brain metastases in patients receiving systemic therapy for advanced melanoma. Wang J; Wei C; Noor R; Burke A; McIntyre S; Bedikian AY Melanoma Res; 2014 Feb; 24(1):54-60. PubMed ID: 24121189 [TBL] [Abstract][Full Text] [Related]
2. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma. Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567 [TBL] [Abstract][Full Text] [Related]
3. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in 1,521 melanoma patients with distant metastases. Barth A; Wanek LA; Morton DL J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677 [TBL] [Abstract][Full Text] [Related]
9. [Cerebral MR imaging of malignant melanoma]. Breckwoldt M; Bendszus M Radiologe; 2015 Feb; 55(2):113-9. PubMed ID: 25589420 [TBL] [Abstract][Full Text] [Related]
10. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors. Tas F; Erturk K Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368 [TBL] [Abstract][Full Text] [Related]
11. Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study. Dummer R; Goldinger SM; Turtschi CP; Eggmann NB; Michielin O; Mitchell L; Veronese L; Hilfiker PR; Felderer L; Rinderknecht JD Eur J Cancer; 2014 Feb; 50(3):611-21. PubMed ID: 24295639 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis. Qian M; Ma MW; Fleming NH; Lackaye DJ; Hernando E; Osman I; Shao Y Melanoma Res; 2013 Dec; 23(6):461-7. PubMed ID: 24165034 [TBL] [Abstract][Full Text] [Related]
13. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. Sampson JH; Carter JH; Friedman AH; Seigler HF J Neurosurg; 1998 Jan; 88(1):11-20. PubMed ID: 9420067 [TBL] [Abstract][Full Text] [Related]
14. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis. Zubatkina I; Ivanov P J Neurosurg; 2018 Aug; 129(2):354-365. PubMed ID: 28841116 [TBL] [Abstract][Full Text] [Related]
15. First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma. Wang X; Haaland B; Hu-Lieskovan S; Colman H; Holmen SL Cancer Rep (Hoboken); 2021 Dec; 4(6):e1419. PubMed ID: 34137219 [TBL] [Abstract][Full Text] [Related]
16. Increased incidence of brain metastases in cutaneous head and neck melanoma. Daryanani D; Plukker JT; de Jong MA; Haaxma-Reiche H; Nap R; Kuiper H; Hoekstra HJ Melanoma Res; 2005 Apr; 15(2):119-24. PubMed ID: 15846145 [TBL] [Abstract][Full Text] [Related]
17. [Metastatic melanoma of the brain]. Konchakova MI; Parshikova SM Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1043-7. PubMed ID: 7293598 [TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631 [TBL] [Abstract][Full Text] [Related]
19. PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma. Marcaillou M; Linder C; Chaltiel L; Sibaud V; Pagès C; Modesto A; Chira C; Dalmasso C; Boulinguez S; Bedane C; Meyer N Melanoma Res; 2020 Dec; 30(6):580-589. PubMed ID: 33156203 [TBL] [Abstract][Full Text] [Related]
20. Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis. Kim M; Suh CH; Lee SM; Park JE; Kim HC; Kim SO; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS AJR Am J Roentgenol; 2021 Nov; 217(5):1184-1193. PubMed ID: 34037408 [No Abstract] [Full Text] [Related] [Next] [New Search]